An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): Report of two cases and review of primary cutaneous Mycocladus infections

Medical Mycology

Volumn 47, Issue 5, 2009, Pages 532-538

  Almaslamani, Muna ^a   Taj Aldeen, Saad J ^b   Garcia Hermoso, Dea ^c   Dannaoui, Eric ^c   Alsoub, Hussam ^a   Alkhal, Abdullatif ^a  

^a Infectious Disease Division

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c INSTITUT PASTEUR   (France)

Author keywords

Amphotericin B; Cutaneous zygomycosis; Fungal infection; Mycocladus corymbifer; Posaconazole; Trauma

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CEFEPIME; CEFTRIAXONE; FUNGAL DNA; INTERNAL TRANSCRIBED SPACER; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; RIBOSOME DNA; SULFAMETHOXAZOLE;

ABSENCE OF SIDE EFFECTS; ABSIDIA; ACCIDENTAL INJURY; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DERMATOMYCOSIS; DISEASE COURSE; DNA SEQUENCE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FUNGAL CONTAMINATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; MALE; MICROSCOPY; MUCORMYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEUS; PSEUDOMONAS AERUGINOSA; RARE DISEASE; SEQUENCE ALIGNMENT; SERRATIA; SKIN CULTURE; STENOTROPHOMONAS; TREATMENT RESPONSE; TREND STUDY; WOUND INFECTION;

ABSIDIA; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEBRIDEMENT; DERMATOMYCOSES; FOOT; HUMANS; LEG; MALE; TRIAZOLES; ZYGOMYCOSIS;

ABSIDIA CORYMBIFERA;

EID: 70749145530     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802595746     Document Type: Article

References (45)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of Zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
2. Ingram CW, Sennesh J. Disseminated zygomycosis: report of four cases and review. Rev Infect Dis 1989; 11: 741-754.
3. Lopes JO, Pereira DV, Streher L A, et al. Cutaneous zygomycosis caused by Absidia corymbifera in a leukemic patient. Mycopathologia 1995; 130: 89-92.
4. Righi E, Giacomazzi CG, Bassetti M, et al. Soft-tissue infection with Absidia corymbifera and kidney complications in an AIDS patient. Med Mycol 2007; 45: 637-640.
5. Cloughley R, Kelehan J, Corbett-Feeney G, et al. Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia. J Clin Microbiol 2002; 40: 725-727.
6. Morales-Aguirre JJ, Agüero-Echeverria WM, Ornelas-Carsolio ME, et al. Successful treatment of a primary cutaneous zygomycosis caused by Absidia corymbifera in a premature newborn. Pediatr Infect Dis J 2004; 23: 470-472.
7. Hammond DE, Winkelmann RK. Cutaneous phycomycosis: report of three cases with identification of Rhizopus. Arch Dermatol 1979; 115: 990-992.
8. Sheldon DL, Johnson WC. Cutaneous mucormycosis: two documented cases of suspected nosocomial cause. J Am Med Ass 1979; 2241: 1032-1034.
9. Christiaens G, Hayette MP, Jacquemin D, et al. An outbreak of Absidia corymbifera infection associated with bandage contamination in burns unit. J Hosp Infect 2005; 61: 88.
10. Gordon G, Indeck M, Bross J, Kapoor D A, Brotman S. Injury from silage wagon accident complicated by mucormycosis. J Trauma 1988; 28: 866-867.
11. Cocanour CS, Miller-Crotchett P, Lawrence Reed R, Johnson PC, Fischer RP. Mucormycosis in trauma patients. J Trauma 1992; 32: 12-15.
12. El Deeb Y, Al Soub H, Almaslamani M, Al Khuwaiter JY, Tajaldeen SJ. Post traumatic cutaneous mucormycosis in an immunocompetent patient. Ann Saudi Med 2005; 25: 343-345.
13. Horré R, Jovanic B, Herff S, et al. Wound infection due to Absidia corymbifera and Candida albicans with fatal outcome. Med Mycol 2004; 42: 373-378.
14. Belfiori R, Terenzi A, Marchesini L, Repetto A. Absidia corymbifera in an immune competent accident victim with multiple abdominal injuries: case report. BMC Infect Dis 2007; 7: 46-50.
15. Taj-Aldeen SJ, Gene J, Al Bozom I, et al. Gangrenous necrosis of the diabetic foot caused by Fusarium acutatum. Med Mycol 2006; 44: 547-552.
16. Schwarz P, Bretagne S, Gantier JC, et al. Molecular identification of zygomycetes from culture and experimentally infected tissue. J Clin Microbiol 2006; 44: 340-349.
17. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST Discussion document. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. http: //www.escmid.org/Files/EUCAST%20moulds%20discussion%20- document-071019.pdf October 2007.
18. Hoffmann K, Discher S, Voigt K. Revision of the genus Absidia (Mucorales, Zygomycetes) based on physiological, phylogenetic, and morphological characters; thermotolerant Absidia spp. From a coherent group, Mycocladiaceae fam. nov. Mycol Res 2007; 111: 1169-1183.
19. de Hoog G, Guarro J, Gené J, Figueras MJ (eds.), Atlas of Clinical Fungi. 2nd ed. Utrecht, The Netherlands and the Rovira I Virgili University, Reus, Spain: Centraalbureau voor Schimmelcultures, 2000.
20. Paterson PJ, Marshall SR, Shaw B, et al. Fatal invasive cerebral Absidia corynbifera infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26: 701-703.
21. Ryan M, Yeo S, Maguire A, et al. Rhinocerebral zygomycosis in childhood acute lymphoblastic leukaemia. Eur J Pediatr 2001; 160: 235-238.
22. Mattner F, Weissbrodt H, Strueber M. Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voricona-zole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient. Scand J Infect Dis 2004; 36: 312-314.
23. Thami GP, Kaur S, Bawa AS, et al. Post-surgical zygomycotic necrotizing subcutaneous infection caused by Absidia corymbifera. Clin Exp Dermatol 2003; 28: 251-253.
24. Hoopwood V, Hicks DA, Thomas S, Evans GV. Primary cutaneous zygomycosis due to Absidia corymbifera in a patient with AIDS. J Med Vet Mycol 1992; 30: 399-402.
25. Jantunen E, Kolho E, Ruutu P, et al. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogenic bone marrow transplantation. Bone Marrow Transplant 1996; 18: 229-230.
26. Leong KW, Crowley B, White B, et al. Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation. Bone Marrow Transplant 1997; 19: 513-515.
27. Amin SB, Ryan RM, Metlay LA, Watson W J. Absidia corymbifera infections in neonates. Clin Infect Dis 1998; 26: 990-992.
28. Seguin P, Musellec H, le Gall F, et al. Post-traumatic course complicated by cutaneous infection with Absidia corymbifera. Eur J Clin Microbiol Infect Dis 1999; 18: 737-739.
29. Scalise A, Barchiesi F, Viviani MA, et al. Infection due to Absidia corymbifera in a patient with a massive crush trauma of foot. J Infect 1999; 38: 191-194.
30. Piens MA, Dannaoui E, Sauzet C, et al. Primary mucormycosis due to Absidia corymbifera in the absence of the risk factors. J Mycol Méd 1999; 9: 230-232.
31. Fazii P, Farina C, Castellaneta E, et al. Post-traumatic soft tissue infection due to Absidia corymbifera. J Mycol Méd 1999; 9: 61-64.
32. Karam A, Ianotto JC, Metges JP, et al. Ulceration of the penis due to Absidia corymbifera. Br J Dermatol 2003; 148: 1270-1290.
33. Buchta V, Kalous P, Otcenašek M, Vánová M. Primary cutaneous Absidia corymbifera infection in a premature newborn. Infection 2003; 31: 57-59.
34. Becker BC, Schuster FR, Ganster B, Seidl HP, Schmid I. Cutaneous mucormycosis in an immunocompromised patient. Lancet Infect Dis 2006; 6: 536.
35. Tiong WHC, Ismael T, McCann J. Post-traumatic and postsurgical Absidia corymbifera infection in a young, healthy man. J Plast Reconstr Aesthet Surg 2006; 59: 1367-1371.
36. Tuzcu A, Bahceci M, Celen MK, Kiline N, Ozmen S. Necrotizing (malignant) otitis externa: An unusal localization of mucormycosis. Indian J Med Microbiol 2006; 24: 289-291.
37. Kindo A J, Shams N R, Srinivasan V, Kalyani J, Mallika M. Multiple discharging sinuses: an unusal presentation caused by Absidia corymbifera. Indian J Med Microbiol 2007; 25: 291-293.
38. Bandettini R, Tuo P, Tamisani AM, Di Marco E, Mantero E. Severe cutaneous zygomycosis: evaluation of treatment with high doses of liposomal amphotericin B in one-year old child. J Chemother 2007; 19: 347-349.
39. Garbino J, Uckay I, Amini K, et al. Absidia Post traumatic infection: successful treatment with posaconazole. J Infect 2005; 51: 135-138.
40. Dannaoui E, Meletiadis J, Mouton JW, Meis JFGM, Verweij PE. Eurofung Network. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45-52.
41. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antmicrob Agents Chemother 2007; 51: 2587-2590.
42. Dannaoui E, Meis JFGM, Loebenberg D, Verweij PE. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 2003; 47: 3647-3650.
43. Greenberg R N, Mullane K, Van Burik J A H, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50: 126-133.
44. Kok J, Gilroy N, Halliday C, et al . Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae. J Infect 2007; 55: e33-e36.
45. Rickerts V, Atta J, Hermann S, et al. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia. Mycoses 2006; 49 (Suppl. 1): 27-30.